![]() | Only 14 pages are availabe for public view |
Abstract Although, replacement of the mitral valve has become relatively a simple procedure, it is not a procedure without complications, as the surgery of mitral valve re-replacement is still a continuing challenge to surgeons.(Matsuyama et al., 2003) Reoperation on prosthetic heart valves is increasingly under consideration for both clinical and prophylactic indications (Piehler et al., 1995) Therefore, therapeutic decision-making is very crucial in these cases and hence requires an accurate assessment of the prognosis of the disease. Such prognosis is generally affected by a large number of factors. The aim of this study was to identify these factors associated with an increased operative risk in mitral valve rereplacement for prosthetic mitral valve dysfunction. The clinical picture of prosthetic valve dysfunction varied according to the type of dysfunction present, such diagnosis can be made by proper history, complete clinical examination and proper investigation. In our study, the diagnosis of prosthetic valve thrombosis, leak, pannus or primary tissue valve failure in symptomatic patients was sufficient indications for reoperation. In cases of prosthetic valve endocarditis, medical treatment started first with antibiotic therapy but this was always interrupted by surgical interference. Patients with suspected prosthetic malfunction, transesophageal echocardiography as well as color Doppler flow velocity mapping gave valuable information more than the transthoracic approach. Strong clinical suspicion of prosthetic valve dysfunction in addition to the finding of echocardiographic study. Once diagnosis was made by these diagnostic tests, other tests such, as cardiac catheterization was not needed as to provide optimal timing to the operation. Early detection and management of prosthetic valve dysfunction carries a better prognosis as once complications have manifested, the patients prognosis depend upon how timely adequate therapeutic management is administered which eventually means reoperation without delay.(Dudeken et al., 1997) Prosthetic valve thrombosis was the most frequent indication for reopertaion in this study, as it remains high even with the newer generations valves. It was concluded that the surgical risk of prosthetic valve rereplacement could be reduced dramatically with no significant difference from that of the primary operation if the intervention is not unduly delayed. The best time for reoperation should be before hemodynamic deterioration and in the presence of preserved left ventricular function. In conclusion, the patient should be urgently diagnosed and prepared without delay before complications start to occur such as renal and hepatic failure, deterioration of NYHA class and the development of pulmonary hypertention. In our study, emergency re-repalcement significantly affected our results in patients who underwent emergency reoperation due to prosthetic valve dysfunction; the mortality was 57.1% in contrast to 8% and 0% operative mortality for urgent and elective reoperation respectively. The left ventricular End-Diastolic Diameter (EDD), postoperative ventricular tachycardia and\or ventricular fibrillation and days ventilated by the patient have significant outcome of the operative mortality |